Interesting ADRO Put Options For February 16th

Investors in Aduro Biotech Inc (ADRO) saw new options become available this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ADRO options chain for the new February 16th contracts and identified the following put contract of particular interest.

The put contract at the $7.50 strike price has a current bid of 50 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $7.50, but will also collect the premium, putting the cost basis of the shares at $7.00 (before broker commissions). To an investor already interested in purchasing shares of ADRO, that could represent an attractive alternative to paying $7.67/share today.

Because the $7.50 strike represents an approximate 2% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 60%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 6.67% return on the cash commitment, or 55.30% annualized — at Stock Options Channel we call this the YieldBoost.

START SLIDESHOW:
Top YieldBoost Puts of the S&P 500 »

Below is a chart showing the trailing twelve month trading history for Aduro Biotech Inc, and highlighting in green where the $7.50 strike is located relative to that history:

Loading+chart++2018+TickerTech.com

The implied volatility in the put contract example above is 95%. Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 253 trading day closing values as well as today's price of $7.67) to be 42%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.

More from Stocks

Allergan Pulls Breast Implant Off European Markets Due to Cancer Risk

Allergan Pulls Breast Implant Off European Markets Due to Cancer Risk

Jabil Stock Surges on Stellar First-Quarter Earnings

Jabil Stock Surges on Stellar First-Quarter Earnings

2019 Could Be a Great Year for Gold Miners

2019 Could Be a Great Year for Gold Miners

Is FedEx Stock Salvageable? Probably, Just Not Yet

Is FedEx Stock Salvageable? Probably, Just Not Yet

Hershey Shares Get Boost From Bank of America's Double Upgrade

Hershey Shares Get Boost From Bank of America's Double Upgrade